Potassium Carbonate → 3-(Benzyloxy)-1-methyl-5-(3-phenyl-1H-pyrazol-1-yl)pyridin-2(1H)-one
반응식
[CH2:1]([O:8][C:9]1[C:10](=[O:17])[N:11]([CH3:16])[CH:12]=[C:13](Br)[CH:14]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:18]1([C:24]2[CH:28]=[CH:27][NH:26][N:25]=2)[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1.C([O-])([O-])=O.[K+].[K+].CNC1CCCCC1NC>O1CCOCC1.CCOC(C)=O.[Cu]I>[CH2:1]([O:8][C:9]1[C:10](=[O:17])[N:11]([CH3:16])[CH:12]=[C:13]([N:26]2[CH:27]=[CH:28][C:24]([C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=3)=[N:25]2)[CH:14]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1참가 물질
반응물 4
생성물 1
시약·촉매·용매 3
반응 조건
- 온도
- 110 °C
실험 절차
3-(Benzyloxy)-5-bromo-1-methylpyridin-2(1H)-one (50 mg, 0.170 mmol), 3-phenyl-1H-pyrazole (29 mg, 0.201 mmol), K2CO3 (47.0 mg, 0.340 mmol), CuI (2 mg, 10.50 μmol), and N,N′-dimethyl-1,2-cyclohexanediamine (6 μl 0.038 mmol) were combined in 1,4-dioxane (0.5 mL) in a screw cap vial. The vial was sealed then heated to 110° C. After stirring overnight the mixture was cooled to RT. CuI (2 mg) and N,N′-dimethyl-1,2-cyclohexanediamine (6 uL) were added and heating continued at 110° C. After stirring overnight the mixture was cooled to RT and diluted with EtOAc. The resulting mixture was filtered and concentrated. The crude material was purified by preparative reversed-phase HPLC (20×150 mm Waters Sunfire (0.1% TFA), 5-70% CH3CN/water over 20 min at 20 mL/min) to give the title compound (33 mg, 54%) as an amber film. 1H NMR (500 MHz, CDCl3): δ 7.85 (d, J=7.7 Hz, 2 H); 7.61 (d, J=2.5 Hz, 1 H); 7.50-7.32 (m, 9 H); 7.12 (d, J=2.6 Hz, 1 H); 6.73 (d, J=2.5 Hz, 1 H); 5.21 (s, 2 H); 3.68 (s, 3 H). LC/MS (M+H)+ 358.
후처리
- customcap vial
- customThe vial was sealed
- temperaturewas cooled to RT
- temperatureheating
- customcontinued at 110° C
- stirringAfter stirring overnight the mixture
- temperaturewas cooled to RT
- filtrationThe resulting mixture was filtered
- concentrationconcentrated
- customThe crude material was purified by preparative reversed-phase HPLC (20×150 mm Waters Sunfire (0.1% TFA), 5-70% CH3CN/water over 20 min at 20 mL/min)
출처 및 근거
- ORD 기록
- ord-7c0eca7314864ade95dd0c29aad64760
- 출처 데이터셋
- uspto-grants-2016_04
- 특허 번호
- US09309199B2
반응 노트
불러오는 중…